Tugal, Claudyn .

HRN: 15-55-44  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/07/2026
01/08/2026
IVT
500mg
Q8
Tmsaf
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines